Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
95.99
+4.37 (4.77%)
At close: Aug 22, 2025, 4:00 PM
95.50
-0.49 (-0.51%)
After-hours: Aug 22, 2025, 7:41 PM EDT
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 13 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $167.08, which forecasts a 74.06% increase in the stock price over the next year. The lowest target is $97 and the highest is $255.
Price Target: $167.08 (+74.06%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 3 |
| Buy | 5 | 6 | 7 | 7 | 7 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Maintains $116 → $97 | Hold | Maintains | $116 → $97 | +1.05% | Aug 15, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $149 → $116 | Hold | Maintains | $149 → $116 | +20.85% | Aug 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy → Hold Downgrades $190 → $125 | Strong Buy → Hold | Downgrades | $190 → $125 | +30.22% | Aug 5, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $270 → $150 | Strong Buy | Maintains | $270 → $150 | +56.27% | Aug 5, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $174 → $101 | Hold | Maintains | $174 → $101 | +5.22% | Aug 5, 2025 |
Financial Forecast
Revenue This Year
968.27M
from 802.80M
Increased by 20.61%
Revenue Next Year
1.14B
from 968.27M
Increased by 17.32%
EPS This Year
2.31
from 1.75
Increased by 32.12%
EPS Next Year
3.30
from 2.31
Increased by 42.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.0B | 1.2B | 1.4B | ||
| Avg | 968.3M | 1.1B | 1.3B | ||
| Low | 921.2M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 24.8% | 23.4% | 24.3% | ||
| Avg | 20.6% | 17.3% | 16.4% | ||
| Low | 14.7% | 10.2% | 6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.52 | 3.90 | 5.93 | ||
| Avg | 2.31 | 3.30 | 4.60 | ||
| Low | 2.16 | 2.76 | 3.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.0% | 68.5% | 79.8% | ||
| Avg | 32.1% | 42.7% | 39.3% | ||
| Low | 23.2% | 19.5% | 14.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.